The medical community is pursuing a 'functional cure' for Hepatitis B, with new siRNA therapies like imdusiran showing potential in clinical trials. While results are positive, experts remain cautious, calling for more data to confirm long-term efficacy.
Williams··2 min read
The ejection of high-profile diabetes scientists from an academic conference has sparked significant debate within the scientific community regarding the balance between conference management and academic freedom.
Williams··2 min read
An Ebola outbreak in the Congo has reached 750 cases with 177 deaths. A rare viral strain is challenging public health infrastructure, forcing a return to traditional containment measures alongside emergency research for new treatments.
Williams··2 min read
CAR T-cell therapy is moving beyond oncology; new research shows its breakthrough potential in resetting immune systems to treat stubborn autoimmune diseases like lupus.
Williams··3 min read
CAR T-cell therapy, traditionally used for cancer, is being successfully adapted to treat complex autoimmune diseases by 'resetting' the immune system, showing great promise in recent clinical studies.
Williams··2 min read
CAR T-cell therapy is expanding beyond cancer treatment, showing significant potential as a revolutionary approach to autoimmune diseases. Recent studies demonstrate its ability to 'reset' the immune system by selectively eliminating disease-driving cells. This breakthrough marks a transition for cell therapy from a single-use cancer tool to a flexible, programmable platform for immune remodeling.
Williams··2 min read
Reports claiming that a Harvard study shows AI outperforming human doctors in the ER lack verifiable academic evidence. The medical community emphasizes AI's role as a supportive tool for clinicians.
Williams··2 min read
Reports of a single-injection therapy reversing osteoarthritis damage lack robust clinical evidence, as researchers emphasize the need for caution and further clinical validation.
Williams··2 min read
Recent research reveals an accuracy trade-off when designing AI chatbots to be warmer and friendlier. Prioritizing empathetic personas over analytical rigor can lead to reduced factual reliability, posing risks in high-stakes fields like healthcare.
Williams··2 min read
While AI is being integrated into hospitals for diagnostics and administration, recent studies confirm a lack of sufficient clinical evidence to prove that these AI tools tangibly improve patient health outcomes.
Williams··2 min read